| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |